In the BioHarmony Drug Report Database

"Preview" Icon

Pentoxifylline

Trental (pentoxifylline) is a small molecule pharmaceutical. Pentoxifylline was first approved as Trental on 1984-08-30. It is used to treat brain ischemia, cerebral malaria, diabetic angiopathies, diabetic neuropathies, and gangrene amongst others in the USA. It is known to target adenosine receptor A2b and cAMP-specific 3′,5′-cyclic phosphodiesterase 4A.

 

Trade Name

 

Trental
 

Common Name

 

pentoxifylline
 

ChEMBL ID

 

CHEMBL628
 

Indication

 

brain ischemia, cerebral malaria, diabetic angiopathies, diabetic neuropathies, gangrene, intermittent claudication, stroke, thrombosis, vasculitis, vasculogenic impotence
 

Drug Class

 

Theophylline derivatives

Image (chem structure or protein)

Pentoxifylline structure rendering